A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.
暂无分享,去创建一个
E. Shimizu | Y. Nishioka | M. Hanibuchi | F. Ogushi | H. Kawano | H. Nokihara | S. Atagi | H. Goto | K. Otsuka | Y. Toyoda | M. Azuma | Mayo Kondo | S. Kakiuchi | Satoshi Sakaguchi | T. Haku | Yuko Toyoda